1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester has been researched along with dactinomycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellomo, G; Hanson, K; Nicotera, P; Orrenius, S; Zhivotovsky, B | 1 |
Okunuki, H; Onose, J; Sawada, J; Teshima, R | 1 |
Antonini, JM; Joseph, P; Klishis, ML; Muchnok, TK; Ong , T; Roberts, JR; Whong, WZ | 1 |
Kawamoto, Y; Kohno, R; Sawada, H; Shibasaki, H; Shimohama, S; Uemura, K | 1 |
Flügel, D; Kietzmann, T; Liu, Q; Möller, U | 1 |
Anand-Srivastava, MB; Li, Y | 1 |
6 other study(ies) available for 1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester and dactinomycin
Article | Year |
---|---|
Ca2+ and endonuclease activation in radiation-induced lymphoid cell death.
Topics: Animals; Apoptosis; Calcium; Cells, Cultured; Cycloheximide; Dactinomycin; Egtazic Acid; Endonucleases; Enzyme Activation; Lymphocytes; Male; Rats; Rats, Sprague-Dawley; Spleen; Thymus Gland | 1993 |
Effect of Ca(2+) ATPase inhibitors on MCP-1 release from bone marrow-derived mast cells and the involvement of p38 MAP kinase activation.
Topics: Animals; Blotting, Western; Bone Marrow Cells; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Chemokine CCL2; Cyclosporine; Dactinomycin; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Female; Hydroquinones; Indoles; Mast Cells; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2000 |
Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.
Topics: 3T3 Cells; Analysis of Variance; Animals; Blotting, Northern; Cadmium; Calcium; Cell Transformation, Neoplastic; Dactinomycin; Egtazic Acid; Flavonoids; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Genes, myc; Indoles; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tumor Cells, Cultured | 2001 |
BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line.
Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Brain-Derived Neurotrophic Factor; Calcium; Cell Line, Tumor; Chelating Agents; Clone Cells; Dactinomycin; Egtazic Acid; Glioma; Humans; Immunoblotting; Immunohistochemistry; Lac Operon; Nerve Growth Factor; Nerve Tissue Proteins; Protein Synthesis Inhibitors; Rats; Recombinant Proteins; RNA, Messenger; Synucleins; Thapsigargin; Transfection | 2004 |
Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1.
Topics: Calcimycin; Calcium; Cell Line, Tumor; Chelating Agents; Cycloheximide; Dactinomycin; Egtazic Acid; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Plasminogen Activator Inhibitor 1; Procollagen-Proline Dioxygenase; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription Factors | 2004 |
Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bucladesine; Calcium; Cell Line; Chelating Agents; Dactinomycin; Drug Interactions; Egtazic Acid; Estrenes; Gallic Acid; Gene Expression Regulation; Genistein; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Type C Phospholipases | 2012 |